Notably, it has been well-established that the APOE gene is an important genetic risk factor for the pathology of AD (Raulin et al., 2022), and its polymorphism is the grave threat determinant of late-onset AD (Yamazaki et al., 2019). Here, APOE is linked to Alzheimer disease.